Topic: Nexavar
According to the American Cancer Society , approximately 19,160 new cases of liver cancer will be diagnosed in the US during 2007. German drug-maker Bayer and its US partner Onyx Pharmaceuticals (Biopharmaceutical company developing innovative therapies that target the molecular mechanisms that ...
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 GlobalData, the industry analysis specialist's new report, "Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global liver cancer ...
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced that more than 70 studies evaluating the use of Nexavar? (sorafenib) tablets will be presented at the 2010 American Society of Clinical Oncology (ASCO) annual meeting, June 4-8, 2010, in Chicago, IL.. ...
Another weak quarter for kidney and liver cancer treatment Nexavar prompted a 5% drop in Onyx Pharmaceuticals' (ONXX) shares Thursday and questions about what exactly is driving the disappointing figures.. Just how concerned followers of the US biotech should be remains to ...
Onyx Pharmaceuticals Changing the Way Cancer is Treated Press Releases Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress. Nexavar's Differentiated Mechanism Nexavar targets both the ...
LONDON (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Bayer's drug Nexavar for treating liver cancer on the state health service, despite a revised charging scheme from the company.Wednesday's decision is a setback for Bayer and its partner Onyx Pharmaceuticals, which ...
ONXX) today announced that more than 65 studies evaluating the use of Nexavar(R) (sorafenib) tablets will be presented at the 2009 American Society of Clinical Oncology (ASCO) annual meeting. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. In RCC ...
NEW YORK (Reuters) - Onyx Pharmaceuticals Inc < said on Sunday it sued Bayer AG < over its rights to an anti-cancer compound that it says it discovered during joint research with the German drugmaker.Onyx's lawsuit, filed in the U.S. District Court ...
The study of Nexavar for liver cancer that was the talk of last year's ASCO conference gets its closeup this week, with publication of the full results in the New England Journal of Medicine. The basic findings are the same as they ...
The study of Nexavar for liver cancer that was the talk of last year's ASCO conference gets its closeup this week, with publication of the full results in the New England Journal of Medicine. The basic findings are the same as they ...
From Around the Web
Video Gallery
-
Cancer: Sorafenib (Nexavar) English
Mechanism of action for Sorafenib (Nexavar). Mécanisme d'action du ...2010-06-14 -
Liver CA: Benefit & Side Effects of ...
In November 2010, Mutu, 48 years old started having coughs ...2011-02-13 -
Mark's Update - Nexavar
I'm taking a new drug Nexavar. This is my ...2008-03-27
